CHANSON INTERNATIONAL HOLD-A (CHSN) Fundamental Analysis & Valuation

NASDAQ:CHSN • KYG2104U2066

Current stock price

0.0393 USD
-0.01 (-26.95%)
Last:

This CHSN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CHSN Profitability Analysis

1.1 Basic Checks

  • CHSN had negative earnings in the past year.
  • In the past year CHSN had a positive cash flow from operations.
  • In multiple years CHSN reported negative net income over the last 5 years.
  • CHSN had a positive operating cash flow in 4 of the past 5 years.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

  • CHSN's Return On Assets of -0.61% is on the low side compared to the rest of the industry. CHSN is outperformed by 67.57% of its industry peers.
  • CHSN has a worse Return On Equity (-1.29%) than 67.57% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -1.29%
ROIC N/A
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • CHSN's Profit Margin has declined in the last couple of years.
  • CHSN's Gross Margin of 40.95% is amongst the best of the industry. CHSN outperforms 91.89% of its industry peers.
  • CHSN's Gross Margin has declined in the last couple of years.
  • CHSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CHSN Health Analysis

2.1 Basic Checks

  • CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CHSN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CHSN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CHSN has an improved debt to assets ratio.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of 0.67, we must say that CHSN is in the distress zone and has some risk of bankruptcy.
  • CHSN has a Altman-Z score of 0.67. This is amonst the worse of the industry: CHSN underperforms 83.78% of its industry peers.
  • The Debt to FCF ratio of CHSN is 3.29, which is a good value as it means it would take CHSN, 3.29 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.29, CHSN is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
  • CHSN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • CHSN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: CHSN outperforms 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.29
Altman-Z 0.67
ROIC/WACCN/A
WACC7.13%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • CHSN has a Current Ratio of 2.00. This indicates that CHSN is financially healthy and has no problem in meeting its short term obligations.
  • CHSN's Current ratio of 2.00 is amongst the best of the industry. CHSN outperforms 86.49% of its industry peers.
  • CHSN has a Quick Ratio of 1.95. This is a normal value and indicates that CHSN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.95, CHSN belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.95
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CHSN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 100.11% over the past year.
  • CHSN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.68% yearly.
  • Looking at the last year, CHSN shows a very strong growth in Revenue. The Revenue has grown by 21.20%.
  • CHSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.70% yearly.
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

Find the best growth stocksShow best growing peers

2

4. CHSN Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHSN indicates a rather cheap valuation: CHSN is cheaper than 97.30% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.03
EV/EBITDA N/A
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CHSN Dividend Analysis

5.1 Amount

  • No dividends for CHSN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHSN Fundamentals: All Metrics, Ratios and Statistics

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (4/28/2026, 11:10:07 AM)

0.0393

-0.01 (-26.95%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap1.53M
Revenue(TTM)19.37M
Net Income(TTM)-315.90K
AnalystsN/A
Price TargetN/A
Short Float %0.27%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 1.03
P/OCF 0.65
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY96.75%
OCF(TTM)0.06
OCFY152.85%
SpS0.5
BVpS0.63
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -1.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.95%
FCFM 7.65%
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.29
Debt/EBITDA N/A
Cap/Depr 111.45%
Cap/Sales 4.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.95
Altman-Z 0.67
F-Score3
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)151.1%
Cap/Sales(3y)5.01%
Cap/Sales(5y)6.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.23%
FCF growth 3YN/A
FCF growth 5Y30.19%
OCF growth 1Y54.05%
OCF growth 3Y25.73%
OCF growth 5Y19.86%

CHANSON INTERNATIONAL HOLD-A / CHSN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHANSON INTERNATIONAL HOLD-A (CHSN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSN.


What is the valuation status of CHANSON INTERNATIONAL HOLD-A (CHSN) stock?

ChartMill assigns a valuation rating of 2 / 10 to CHANSON INTERNATIONAL HOLD-A (CHSN). This can be considered as Overvalued.


Can you provide the profitability details for CHANSON INTERNATIONAL HOLD-A?

CHANSON INTERNATIONAL HOLD-A (CHSN) has a profitability rating of 2 / 10.